Clinical Trial Update: Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing whether nebivolol can reverse inappropriate left ventricular mass in hypertensive patients; the study was terminated and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

Sponsor: Mayo Clinic | Conditions: Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2014-05-07